Harnessing benefit from targeting tumor associated carbohydrate antigens

von Kieber-Emmons, Thomas, Monzavi-Karbassi, Behjatolah, Hutchins, Laura F., Pennisi, Angela, Makhoul, Issam
Veröffentlicht in Hum Vaccin Immunother (2016)

Role of EZH2 histone methyltrasferase in melanoma progression and metastasis

von Mahmoud, Fade, Shields, Bradley, Makhoul, Issam, Hutchins, Laura F., Shalin, Sara C., Tackett, Alan J.
Veröffentlicht in Cancer Biol Ther (2016)

Merkel Cell Carcinoma: Epidemiology, Target, and Therapy

von Hughes, Mathew P., Hardee, Matthew E., Cornelius, Lynn A., Hutchins, Laura F., Becker, Jurgen C., Gao, Ling
Veröffentlicht 2014

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

von Mahmoud, Fade, Shields, Bradley, Makhoul, Issam, Avaritt, Nathan, Wong, Henry K., Hutchins, Laura F., Shalin, Sara, Tackett, Alan J.
Veröffentlicht in Cancer Biol Ther (2017)

Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897

von Hershman, Dawn L., Unger, Joseph M., Barlow, William E., Hutchins, Laura F., Martino, Silvana, Osborne, C. Kent, Livingston, Robert B., Albain, Kathy S.
Veröffentlicht 2009

High Circulating Tie-2 is Associated with Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer

von Makhoul, Issam, Griffin, Robert J., Siegel, Eric, Lee, Jeannette, Dhakal, Ishwori, Raj, Vinay, Jamshidi-Parsian, Azemat, Klimberg, Suzanne, Hutchins, Laura F., Kadlubar, Susan
Veröffentlicht in Am J Clin Oncol (2016)

Pre-diagnosis blood glucose and prognosis in women with breast cancer

von Monzavi-Karbassi, Behjatolah, Gentry, Rhonda, Kaur, Varinder, Siegel, Eric R., Jousheghany, Fariba, Medarametla, Srikanth, Fuhrman, Barbara J., Safar, A. Mazin, Hutchins, Laura F., Kieber-Emmons, Thomas
Veröffentlicht in Cancer Metab (2016)

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

von Hutchins, Laura F., Makhoul, Issam, Emanuel, Peter D., Pennisi, Angela, Siegel, Eric R., Jousheghany, Fariba, Guo, Xueyan, Pashov, Anastas D., Monzavi-Karbassi, Behjatolah, Kieber-Emmons, Thomas
Veröffentlicht in Oncotarget (2017)

Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Malignant Melanoma: Southwest Oncology Group S0508

von Clark, Joseph I., Moon, James, Hutchins, Laura F., Sosman, Jeffrey A., Kast, W. Martin, Da Silva, Diane M., Liu, P.Y., Thompson, John A., Flaherty, Lawrence E., Sondak, Vernon K.
Veröffentlicht 2010

Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study

von Hernandez Puente, Cinthia Violeta, Hsu, Ping-Ching, Rogers, Lora J., Jousheghany, Fariba, Siegel, Eric, Kadlubar, Susan A., Beck, J. Thaddeus, Makhoul, Issam, Hutchins, Laura F., Kieber-Emmons, Thomas, Monzavi-Karbassi, Behjatolah
Veröffentlicht in Front Oncol (2020)

A Prospective Analysis of the Influence of Older Age on Physician and Patient Decision-Making When Considering Enrollment in Breast Cancer Clinical Trials (SWOG S0316)

von Javid, Sara H., Unger, Joseph M., Gralow, Julie R., Moinpour, Carol M., Wozniak, Antoinette J., Goodwin, J. Wendall, Lara, Primo N., Williams, Pamela A., Hutchins, Laura F., Gotay, Carolyn C., Albain, Kathy S.
Veröffentlicht 2012

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients

von Makhoul, Issam, Todorova, Valentina K., Siegel, Eric R., Erickson, Stephen W., Dhakal, Ishwori, Raj, Vinay R., Lee, Jeannette Y., Orloff, Mohammed S., Griffin, Robert J., Henry-Tillman, Ronda S., Klimberg, Suzanne, Hutchins, Laura F., Kadlubar, Susan A.
Veröffentlicht in PLoS One (2017)

Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination

von Coleman, Hannah N., Greenfield, William W., Stratton, Shawna L., Vaughn, Rita, Kieber, Alexander, Moerman-Herzog, Andrea M., Spencer, Horace J., Hitt, Wilbur. C., Quick, Charles Matthew, Hutchins, Laura F., Mackintosh, Samuel G., Edmondson, Ricky D., Erickson, Stephen W., Nakagawa, Mayumi
Veröffentlicht in Cancer Immunol Immunother (2016)

Nitric oxide synthase (NOS3) variants and disease-free survival among treated and untreated breast cancer patients in a SWOG Clinical Trial (S8897)

von Choi, Ji-Yeob, Barlow, William E., Albain, Kathy S., Hong, Chi-Chen, Blanco, Javier G., Livingston, Robert B., Davis, Warren, Rae, James M., Yeh, I-Tien, Hutchins, Laura F., Ravdin, Peter M., Martino, Silvana, Lyss, Alan P., Osborne, C. Kent, Abeloff, Martin D., Hayes, Daniel F., Ambrosone, Christine B.
Veröffentlicht 2009

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

von Yao, Song, Barlow, William E., Albain, Kathy S., Choi, Ji-Yeob, Zhao, Hua, Livingston, Robert B., Davis, Warren, Rae, James M., Yeh, I-Tien, Hutchins, Laura F., Ravdin, Peter M., Martino, Silvana, Lyss, Alan P., Osborne, C. Kent, Abeloff, Martin D., Hortobagyi, Gabriel N., Hayes, Daniel F., Ambrosone, Christine B.
Veröffentlicht 2010

Gene polymorphisms in cyclophosphamide metabolism pathway, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

von Yao, Song, Barlow, William E., Albain, Kathy S., Choi, Ji-Yeob, Zhao, Hua, Livingston, Robert B., Davis, Warren, Rae, James M., Yeh, I-Tien, Hutchins, Laura F., Ravdin, Peter M., Martino, Silvana, Lyss, Alan P., Osborne, C. Kent, Abeloff, Martin, Hortobagyi, Gabriel N., Hayes, Daniel F., Ambrosone, Christine B.
Veröffentlicht 2010

Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study

von Larsen, Victoria, Barlow, William E., Yang, Jun J., Zhu, Qianqian, Liu, Song, Kwan, Marilyn, Ergas, Isaac J., Roh, Janise M., Hutchins, Laura F., Kadlubar, Susan A, Albain, Kathy S., Rae, James M., Yeh, I-Tien, Ravdin, Peter M., Martino, Silvana, Lyss, Alan P., Osborne, C. Kent, Hortobagyi, Gabriel N., Kushi, Lawrence H., Hayes, Daniel F., Ambrosone, Christine B., Yao, Song
Veröffentlicht in Clin Breast Cancer (2019)

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

von Tarhini, Ahmad A, Kang, Ni, Lee, Sandra J, Hodi, F Stephen, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriet M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M
Veröffentlicht in J Immunother Cancer (2021)

A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women w...

von Greenfield, William W, Stratton, Shawna L, Myrick, Rebecca S, Vaughn, Rita, Donnalley, Lisa M, Coleman, Hannah N, Mercado, Maria, Moerman-Herzog, Andrea M, Spencer, Horace J, Andrews-Collins, Nancy R, Hitt, Wilbur C, Low, Gordon M, Manning, Nirvana A, McKelvey, Samantha S, Smith, Dora, Smith, Michael V, Phillips, Amy M, Quick, C Matthew, Jeffus, Susanne K, Hutchins, Laura F, Nakagawa, Mayumi
Veröffentlicht in Oncoimmunology (2015)

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

von Tarhini, Ahmad A., Lee, Sandra J., Hodi, F. Stephen, Rao, Uma N. M., Cohen, Gary I., Hamid, Omid, Hutchins, Laura F., Sosman, Jeffrey A., Kluger, Harriett M., Eroglu, Zeynep, Koon, Henry B., Lawrence, Donald P., Kendra, Kari L., Minor, David R., Lee, Carrie B., Albertini, Mark R., Flaherty, Lawrence E., Petrella, Teresa M., Streicher, Howard, Sondak, Vernon K., Kirkwood, John M.
Veröffentlicht in J Clin Oncol (2020)